This article was originally published in The Tan Sheet
Stamford, Conn.-based firm announces resumed shipment of several OTC product lines after manufacturing difficulties, including Betadine microbicides, Colace stool softeners, Gentlax Tablets and Slow-Mag Tablets. "We are working hard to ensure that our full line of OTC products is back on the market and actively promoted as soon as possible, including the Senokot Laxative family of products," said Steve Seid, Exec Director-National Accounts & Trade Relations Feb. 22. Purdue acquired Colace and Slow-Mag last year to bolster consumer health business (1"The Tan Sheet" Jan. 6, 2003, p. 12)...
You may also be interested in...
Purdue Pharma's acquisition of the Colace stool softener, Peri-Colace laxative capsule and Slow-Mag dietary supplement brands from Shire Pharmaceuticals Group is part of the firm's strategy to grow and diversify its consumer health business
A trial will begin next month in Mylan’s bid to overcome patents shielding AstraZeneca’s Symbicort respiratory brand in the US. With rival Teva having previously settled ANDA action, Mylan is in the driving seat for a first substitutable generic.
Fresenius Kabi’s decision to add radio frequency-identification (RFID) tags to 24 products used in hospital operating rooms will help the company’s hospital pharmacy customers reduce waste, increase efficiencies and facilitate tighter medication inventory control, executives claim. However, only 10% of US hospitals are currently equipped to scan and process RFID tags, despite larger adoption rates in other industry sectors. COVID-19-related revenue losses may push more hospitals to adopt automated RFID medication management systems to save time and reduce labor costs.